Draft Recommendation Statement and Draft Evidence Reviews: Screening for HIV - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Reviews: Screening for HIV

Public Comment on Draft Recommendation Statement and Draft Evidence Reviews: Screening for HIV Infection The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on screening for HIV infection. The Task Force found that clinicians should screen for HIV in adolescents, adults, and pregnant women. The draft recommendation statement and draft evidence reviews are available for review and public comment from November 20, 2018 to December 26, 2018 here. The Draft Recommendation Statement and Draft Evidence Reviews Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 11/20/18-12/26/18 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Adolescents and adults ages 15 to 65 years The USPSTF recommends that clinicians screen for HIV infection in adolescents and adults ages 15 to 65 years. Younger adolescents and older adults who are at increased risk for infection should also be screened. A Pregnant women The USPSTF recommends that clinicians screen for HIV infection in all pregnant women, including those who present in labor or at delivery whose HIV status is unknown. A

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary